The in vitro component demonstrated that both glucagon and Retatrutide directly decreased ANGPTL3/8 secretion from hepatocytes, and this effect was blocked by a glucagon receptor (GCGR) antagonist
Some counterfeit products may still be available for purchase
Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers Legal Alerts 2.12.26 Takeaways The bill would limit 503A pharmacies from compounding large volumes of drugs that are essentially copies of commercially available FDA-approved products
Tirzepatide is the active ingredient in FDA-approved products marketed by other manufacturers
The pen versions of GLP-1s are delivered via subcutaneous injections meaning they are injected into the fatty tissue layer just below the skin, typically in the abdomen, thigh, or upper arm
Our team has been at the forefront of this evolution, and we're here to walk you through everything